Verapamil Hydrochloride Structural Formula (4076efcd B33a 48e2 Bd8e D19d8ff44fb1 01)
Verapamil Hydrochloride Capsule, Extended Release
Product Images NDC 0378-6380
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 0378-6380). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Verapamil Hydrochloride Extended-release Capsules, Usp 120 mg Bottle Label (Image 01)
The text seems to be a description of a medication in the form of extended-release capsules containing 120 mg of hydrochloride. The medication is manufactured by Mylan Pharmaceuticals Inc. and should be stored in a cool and dry place below 25°C. The description also includes a caution to avoid excessive heat and protect from moisture. The identification number of the capsule is NDC 0378-6320-01.*
Verapamil Hydrochloride Extended-release Capsules, Usp 180 mg Bottle Label (Image 02)
Verapamil is a medication available in the form of extended-release capsules. It contains Hydrochloride, USP 180 mg and is packaged in a tight, resistant closure. The medication should be kept away from children and stored at a temperature between 20° to 25°C (66° to 77°F) as per the USP Controlled Room Temperature guidelines. The manufacturer of Verapamil is Wylan Pharmaceuticals Inc with registered offices in West Virginia, USA. The rest of the text contains unreadable characters.*
Verapamil Hydrochloride Extended-release Capsules, Usp 240 mg Bottle Label (Image 03)
This is a description of hydrochloride capsules with a strength of 20mg. Each Mylan® Rxonly 100 capsule contains chlorthalidone and should be kept in a tight, light-resistant container. The medication should be stored in a temperature controlled environment between 20°-25° C (68 to 77° F) and protected from excessive heat, and moisture. The recommended dosage should be determined by a healthcare provider based on individual medical needs. These capsules are marketed by Mylan Pharmaceuticals Inc. and are available only by prescription.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
